|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.34 USD | +1.18% |
|
+7.34% | -24.75% |
| Jun. 25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| Jun. 24 | Abbott Laboratories, ALZpath Sign Global Licensing Deal for Alzheimer's Disease Diagnostic | MT |
| Market Cap | 162B 142B 131B 123B 230B 15,320B 235B 1,578B 610B 7,572B 610B 597B 26,255B | P/E 2026 * |
23.4x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 174B 153B 141B 132B 247B 16,426B 252B 1,692B 655B 8,118B 654B 640B 28,151B | EV / Sales 2026 * |
3.46x | EV / Sales 2027 * | 3.13x |
| Free-Float |
86.73% | Yield 2026 * |
2.73% | Yield 2027 * | 2.91% |
Last Transcript: Abbott Laboratories
| 1 day | +1.09% | ||
| 1 week | +7.49% | ||
| Current month | +10.29% | ||
| 1 month | +8.93% | ||
| 3 months | -9.72% | ||
| 6 months | -24.38% | ||
| Current year | -24.65% |
| 1 week | 87.21 |  | 95.21 |
| 1 month | 84.96 | | 95.21 |
| Current year | 81.97 | | 129.46 |
| 1 year | 81.97 | | 137.49 |
| 3 years | 81.97 | | 141.23 |
| 5 years | 81.97 | | 142.6 |
| 10 years | 36.76 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Apr. 27 | Other | Head of Human Resources | 5,314 | 0.0003% | ||
| Apr. 23 | Free | Director | 2,286 | 0.0001% | ||
| Apr. 23 | Free | Director | 2,286 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +7.49% | -29.37% | -12.99% | 162B | |
| +1.32% | +2.11% | -6.08% | -6.97% | 103B | |
| +0.58% | +6.26% | -2.81% | +53.52% | 55.83B | |
| -2.09% | -10.31% | +49.00% | +52.19% | 54.05B | |
| +2.41% | +10.23% | -8.75% | -39.53% | 41.71B | |
| +2.66% | +11.64% | - | - | 31.94B | |
| +0.98% | +0.27% | -18.56% | -44.43% | 26.49B | |
| -0.19% | +5.02% | +58.10% | -5.16% | 24.48B | |
| +2.26% | +7.39% | -9.78% | +1.51% | 20.52B | |
| +0.84% | -2.08% | -17.51% | -3.19% | 20.02B | |
| Average | +0.99% | +1.24% | +1.58% | -0.56% | 54.05B | |
| Weighted average by Cap. | +0.94% | +2.07% | -5.68% | -0.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.29B 44.09B 40.64B 38.05B 71.35B 4,744B 72.83B 489B 189B 2,345B 189B 185B 8,130B | 54.79B 48.04B 44.28B 41.46B 77.74B 5,169B 79.36B 532B 206B 2,555B 206B 201B 8,858B |
| Net income | 7.02B 6.15B 5.67B 5.31B 9.96B 662B 10.17B 68.18B 26.38B 327B 26.36B 25.78B 1,135B | 8.39B 7.36B 6.78B 6.35B 11.91B 792B 12.15B 81.52B 31.55B 391B 31.51B 30.82B 1,357B |
| Net Debt | 11.73B 10.28B 9.48B 8.87B 16.64B 1,106B 16.98B 114B 44.08B 547B 44.03B 43.07B 1,896B | 8.88B 7.79B 7.18B 6.72B 12.6B 838B 12.87B 86.29B 33.39B 414B 33.36B 32.63B 1,436B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | $94.25 | +1.08% | 4,309,306 |
| 26-06-25 | $93.24 | +3.04% | 16,708,691 |
| 26-06-24 | $90.49 | -0.04% | 13,201,602 |
| 26-06-23 | $90.53 | +3.07% | 12,201,914 |
| 26-06-22 | $87.83 | -0.66% | 11,458,235 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
